| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $774K | — | +70.2% |
| Cost of Revenue | $598K | — | +155.6% |
| Gross Profit | $175K | — | -20.4% |
| R&D Expense | $138K | — | -34.4% |
| SG&A Expense | $1.6M | — | +45.7% |
| Income Tax | $0 | — | — |
| Net Income | -$2.3M | — | -29.8% |
| EPS (Basic) | -$0.37 | — | +48.6% |
| EPS (Diluted) | -$0.37 | — | +48.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.4M | -32.8% | -16.7% |
| Accounts Receivable | $72K | -49.7% | -20.3% |
| Inventory | $1.4M | -19.5% | +24.5% |
| Current Assets | $8.7M | -7.3% | +19.4% |
| Total Assets | $9.5M | -6.5% | +19.4% |
| Current Liabilities | $1.1M | +4.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.5M | — | -7.8% |
| Capital Expenditures | $41K | — | +0.0% |
| Investing Cash Flow | -$1.0M | — | -121.2% |
| Financing Cash Flow | $1.4M | — | — |
| Free Cash Flow | -$2.5M | — | -7.6% |
| +143.9% |
| Total Liabilities | $1.1M | +3.5% | +148.4% |
| Stockholders' Equity | $8.4M | -7.7% | +11.7% |